M&A

News

Sanofi steals in to buy Ablynx for €3.9 billion

Sanofi has leapt in to buy Ablynx for €3.9 billion ($4.85bn) outbidding an offer from Novo Nordisk which the European biotech had declined two weeks ago.

News

Celgene seals Juno acquisition for $9bn

Celgene has today confirmed that it will acquire Juno Therapeutics for $9 billion, and says the move will make it a leader in cell immunotherapy.

News

Chinese buyers interested in J&J diabetes devices business

Decision follows J&J's decision to close Animas insulin pump business

News

Novo Nordisk must increase Ablynx bid, says shareholder

Novo Nordisk must up its bid to take over Belgian biotech Ablynx, after the company’s largest shareholder reportedly said its 2.6 billion euro ($3.18 billion) offer was too low.

News